International Issues

June 8, 2020
Senate Finance Committee Holds Hearing on FDA’s Foreign Drug Manufacturing Inspection Process
June 4, 2020
China Publishes Draft Notice on Convergence Matters Related to Transition from MEP Order No. 7 to MEE Order No. 12
May 8, 2020
China Publishes Long-Awaited Revised MEP Order No. 7
April 2, 2020
Russian Federation Accepting Nominations to New Chemical Inventory
March 27, 2020
India Announces Fourth Draft Chemicals (Management and Safety) Rules
December 18, 2019
EC Begins Public Consultations on Fitness Check of EU Legislation Regarding Endocrine Disruptors
December 13, 2019
FAQs Regarding Brexit—What Chemical Companies Need To Know
December 9, 2019
Requirements for South Korean Manufacturers and Importers of Chemicals Continue to Change
September 18, 2019
EC Proposes REACH Restriction For PVC Articles Containing Lead And Lead Compounds and Other Recent REACH Developments
August 28, 2019
Australia’s New Scheme for Introducing Industrial Chemicals Will Begin July 1, 2020
 1 2 3 >  Last › View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2020 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.